All Updates

All Updates

icon
Filter
Funding
M&A
BehaVR and OxfordVR merge and raise USD 13 million
Extended Reality
Dec 14, 2022
This week:
Funding
Matr Foods raises EUR 20 million in debt funding to build mycelium meat factory
Plant-based Meat
Today
Last week:
M&A
Platform Science to acquire Trimble's global transportation telematics business units
Truck Industry Tech
Yesterday
Funding
Whatfix raises USD 100 million in Series E funding to expand business
EdTech: Corporate Learning
Yesterday
Product updates
Sky Mavis launches cross-game onboarding solution
Web3 Ecosystem
Sep 14, 2024
Funding
Bicara Therapeutics raises USD 315 million in IPO; plans to develop lead candidate ficerafusp alfa
Precision Medicine
Sep 13, 2024
Partnerships
Massive Bio and Foundation Medicine partner to improve cancer clinical trial enrollment
Precision Medicine
Sep 13, 2024
Partnerships
Moffitt Cancer Center partners with AstraZeneca to advance oncology cell therapies
Cell & Gene Therapy
Sep 13, 2024
Product updates
Quandela launches European quantum computer in North America
Quantum Computing
Sep 13, 2024
Partnerships
IonQ achieves high qubit gate fidelity on barium development platform
Quantum Computing
Sep 13, 2024
Partnerships
Massive Bio and Foundation Medicine partner to improve cancer clinical trial enrollment
Clinical Trial Technology
Sep 13, 2024
Extended Reality

Extended Reality

Dec 14, 2022

BehaVR and OxfordVR merge and raise USD 13 million

Funding
M&A

  • Virtual reality (VR) based mental health providers BehaVR and OxfordVR merged to form the largest virtual reality healthcare delivery platform. The providers will merge and operate under BehaVR’s brand with BehaVR's founder CEO Aaron Gani leading the company, with Dr. Daniel Freeman, OxfordVR's founder, being a part of the leadership team. 

  • The merged entities raised USD 13 million in a Series B funding round co-led by Oxford Science Enterprises and Optum Ventures, along with participation from other venture capital firms. The funds raised will be used to support the merger of the two entities.

  • The combined entity will continue to provide BehvaVR’s clinically validated and VR-based treatments for mental and behavioral health conditions and chronic diseases while including OxfordVR’s FDA-approved automated cognitive-behavioral VR therapy “gameChange.” 

  • BehaVR is a virtual reality (VR)-based mental health startup that provides digital therapy to clients through virtual reality, cloud computing, and machine learning. It allows VR sessions to be personalized and engaging through patient experience logs and responses being captured and analyzed.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.